Verition Fund Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-567,683
Closed -$2.16M 3035
2025
Q4
$2.16M Hold
567,683
0.01% 1537
2025
Q3
$1.83M Hold
567,683
0.01% 2051
2025
Q2
$1.64M Hold
567,683
0.01% 2099
2025
Q1
$1.22M Sell
567,683
-470,065
-45% -$1.49M 0.01% 1967
2024
Q4
$4.02M Sell
1,037,748
-124,002
-11% -$819K 0.02% 1045
2024
Q3
$7.61M Sell
1,161,750
-432,400
-27% -$3.48M 0.05% 561
2024
Q2
$11.6M Buy
1,594,150
+92,531
+6% +$709K 0.09% 293
2024
Q1
$11.4M Sell
1,501,619
-1,309,512
-47% -$10.2M 0.11% 288
2023
Q4
$12.8M Sell
2,811,131
-89,407
-3% -$302K 0.13% 182
2023
Q3
$11.5M Buy
2,900,538
+183,825
+7% +$695K 0.15% 180
2023
Q2
$8.5M Buy
2,716,713
+777,891
+40% +$3.17M 0.13% 244
2023
Q1
$8.78M Buy
1,938,822
+462,598
+31% +$2.42M 0.14% 221
2022
Q4
$6.1M Buy
1,476,224
+84,888
+6% +$290K 0.12% 263
2022
Q3
$4.45M Buy
1,391,336
+987,446
+244% +$2.47M 0.06% 476
2022
Q2
$792K Sell
403,890
-20,709
-5% -$61.2K 0.02% 1161
2022
Q1
$1.72M Buy
424,599
+188,764
+80% +$1.24M 0.03% 1080
2021
Q4
$2.54M Buy
235,835
+156,179
+196% +$1.74M 0.03% 717
2021
Q3
$918K Sell
79,656
-165,019
-67% -$1.98M 0.01% 966
2021
Q2
$2.4M Buy
244,675
+15,374
+7% +$174K 0.04% 465
2021
Q1
$3.35M Buy
229,301
+106,194
+86% +$1.93M 0.06% 281
2020
Q4
$2.64M Buy
123,107
+71,107
+137% +$1.42M 0.04% 320
2020
Q3
$789K Buy
+52,000
New +$658K 0.03% 433

Other funds holding LRMR